Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Oral Type I Collagen for Relieving Scleroderma

ClinicalTrials.gov ID: NCT00005675

Public ClinicalTrials.gov record NCT00005675. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 9:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter Phase II Trial of Oral Type I Bovine Collagen in Scleroderma

Study identification

NCT ID
NCT00005675
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NIH
Enrollment
168 participants

Conditions and interventions

Interventions

  • Oral bovine type I collagen Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2000
Primary completion
Apr 30, 2005
Completion
Not listed
Last update posted
May 24, 2010

Started 2000

United States locations

U.S. sites
12
U.S. states
12
U.S. cities
12
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
University of California Los Angeles Los Angeles California 90024
University of Connecticut Farmington Connecticut 06030-1310
Georgetown University Medical Center Washington D.C. District of Columbia 20007
Johns Hopkins University Baltimore Maryland 21224
Boston University School Of Medicine Boston Massachusetts 02188
Wayne State University Detroit Michigan 48201
Beth Israel Medical Center New York New York 10003
Medical University of South Carolina Charleston South Carolina 29425
University of Tennessee Health Science Center Memphis Tennessee 38163
The University of Texas Health Science Center at Houston Houston Texas 77030
Virginia Mason Research Center Seattle Washington 98101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00005675, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 24, 2010 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00005675 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →